Sartorius Stedim Biotech S.A.
Research Sartorius Stedim Biotech S.A. (DIM.PA) on Bullrun: market cap EUR 20.70B, P/E 70.7, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDIM.PA
- ExchangeXPAR
- CountryFrance
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 20.70B
- P/E70.7
- Dividend yield0.3%
- Financial periodQ2 2026
- RevenueEUR 765.70M
- Net incomeEUR 93.00M
- Free cash flowEUR 75.10M
- Gross margin46.9%
Valuation Snapshot
latest market cap is EUR 20.70B; P/E is 70.7; dividend yield is 0.3%.
Peer valuation comparison
Latest P/E is 70.7x versus a Healthcare sector median of 24.6x (187.4% above).
Latest dividend yield is 0.32% versus a Healthcare sector median of 1.84% (82.6% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-10 | EUR 20.70B | 70.7 | 0.3% | 0.69 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.69 EUR, yield 0.3%.
About Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services;
ETFs that hold Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. is one of the ten largest holdings of 3 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| Invesco MSCI Europe Equal Weight UCITS ETF Acc | 0.32% | 0.20% |
| Frankfurter UCITS ETF - Modern Value Fund | 4.49% | 0.54% |
| Invesco MSCI Europe Equal Weight UCITS ETF Dist | 0.32% | 0.20% |
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sartorius Stedim Biotech S.A.'s market cap?
Sartorius Stedim Biotech S.A.'s market capitalization is EUR 20.70B.
What is Sartorius Stedim Biotech S.A.'s P/E ratio?
Sartorius Stedim Biotech S.A.'s price-to-earnings (P/E) ratio is 70.7.
Does Sartorius Stedim Biotech S.A. pay a dividend?
Sartorius Stedim Biotech S.A. has a dividend yield of 0.3%.
What does Sartorius Stedim Biotech S.A. do?
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products.